food-related metabolome and gut microbiota

2
www.vtt.fi Food-related metabolome and gut microbiota F ood structure and composition are crucial factors influencing di- gestion. Food components are released from food matrix and the digestible part of the com- ponents is absorbed. Components, which structurally resist the absorption, retain in the food matrix and are subjected to colonic metabolism. Colonic microbiota degrades the matrix and converts released components to differ- ent metabolites, the role of which is receiving increasing interest due to their long residence time in the body. What is the role of food ma- trix in this process? What is the role of the gut microbiota in this process? Are there un- known metabolites? We offer a solution ad- dressing these questions for the pre-clinical phase. Food is digested in the upper intestine, where nutrients (glucose, amino acids, lipids) and phenolic components are released and absorbed. Absorbed phenolic components are metabolised further in the liver. A part of these compounds is returned to the intestinal VTT offers services for companies, when there is an interest in knowing how the products behave in the digestive tract. These services include identification of the food-specific metabolome by using a colon model and connecting this data to corresponding characterization of plasma and urine, and furthermore an assessment of diet-related compositional changes in colonic microbiota from human interventions. lumen. This circulation is called “enterohepat- ic circulation”. However, an indigestible part is delivered to the colon, which contains about 1.5 kg of microbes taking actively part in the degradation of the indigestible intake. Modelling colonic activities VTT has developed an in vitro colon model to mimic these degradation and conversion processes. A good correlation has been found for phenolic microbial metabolites between the in vitro colon model and in vi- vo metabolite profiles from human body flu- ids, plasma and urine. After conversion mi- crobial metabolites are also absorbed and undergo the same enterohepatic circulation, which causes a long residence time in plas- ma; e.g. up to 35 hours after intake of phe- nolic compounds. VTT’s in vitro models VTT has created two in vitro models - an en- zymatic digestion model and a batch colon model coupled with different analytical tools - to address these challenges. Business from technology Enzymatic digestion model can be used for release of nutritional components and for removal of components to produce a non- digestible residue for the colon model. VTT’s in vitro colon model is a strictly anaerobic in- cubation with a suspension of fresh human faeces. Metabolites are profiled and quanti- fied by targeted analysis of microbial metab- olites or by large scale profiling tools using a metabolomic platform. Thus we can study the time course of microbial activity. Besides the in vitro models, we also have the tools to quantify and study the diversi- ty and temporal stability of the major bacte- rial groups of the human gut microbiota. All these tools together enable the assessment of subtle differences between food products i.e. the effect of food processing and between metabolomes in the model as compared to those in human body fluids (plasma and urine) (in vitro-in vivo correlation). The fecal bacte- rial profiles may also be utilised for the in vitro – in vivo correlation. If the models are used as a pre-clinical tool, potential biomarkers of a healthy diet can be revealed.

Upload: others

Post on 12-Feb-2022

6 views

Category:

Documents


0 download

TRANSCRIPT

www.vtt.fi

Food-related metabolome and gut microbiota

Food structure and composition

are crucial factors influencing di-

gestion. Food components are

released from food matrix and

the digestible part of the com-

ponents is absorbed. Components, which

structurally resist the absorption, retain in

the food matrix and are subjected to colonic

metabolism.

Colonic microbiota degrades the matrix

and converts released components to differ-

ent metabolites, the role of which is receiving

increasing interest due to their long residence

time in the body. What is the role of food ma-

trix in this process? What is the role of the

gut microbiota in this process? Are there un-

known metabolites? We offer a solution ad-

dressing these questions for the pre-clinical

phase.

Food is digested in the upper intestine,

where nutrients (glucose, amino acids, lipids)

and phenolic components are released and

absorbed. Absorbed phenolic components

are metabolised further in the liver. A part of

these compounds is returned to the intestinal

VTT offers services for companies, when there is an interest in knowing how the products behave in the digestive tract. These services include identification of the food-specific metabolome by using a colon model and connecting this data to corresponding characterization of plasma and urine, and furthermore an assessment of diet-related compositional changes in colonic microbiota from human interventions.

lumen. This circulation is called “enterohepat-

ic circulation”. However, an indigestible part is

delivered to the colon, which contains about

1.5 kg of microbes taking actively part in the

degradation of the indigestible intake.

Modelling colonic activitiesVTT has developed an in vitro colon model

to mimic these degradation and conversion

processes. A good correlation has been

found for phenolic microbial metabolites

between the in vitro colon model and in vi-

vo metabolite profiles from human body flu-

ids, plasma and urine. After conversion mi-

crobial metabolites are also absorbed and

undergo the same enterohepatic circulation,

which causes a long residence time in plas-

ma; e.g. up to 35 hours after intake of phe-

nolic compounds.

VTT’s in vitro modelsVTT has created two in vitro models - an en-

zymatic digestion model and a batch colon

model coupled with different analytical tools

- to address these challenges.

Business from technology

Enzymatic digestion model can be used

for release of nutritional components and for

removal of components to produce a non-

digestible residue for the colon model. VTT’s

in vitro colon model is a strictly anaerobic in-

cubation with a suspension of fresh human

faeces. Metabolites are profiled and quanti-

fied by targeted analysis of microbial metab-

olites or by large scale profiling tools using a

metabolomic platform. Thus we can study

the time course of microbial activity.

Besides the in vitro models, we also have

the tools to quantify and study the diversi-

ty and temporal stability of the major bacte-

rial groups of the human gut microbiota. All

these tools together enable the assessment

of subtle differences between food products

i.e. the effect of food processing and between

metabolomes in the model as compared to

those in human body fluids (plasma and urine)

(in vitro-in vivo correlation). The fecal bacte-

rial profiles may also be utilised for the in vitro

– in vivo correlation. If the models are used

as a pre-clinical tool, potential biomarkers of a

healthy diet can be revealed.

Additional information

In vitro digestion models

Dr. Anna-Marja Aura

Tel. +358 40 820 8731

[email protected]

VTT’s tools to study how food behaves in a model

Release of bioactive components from •

food matrix

• Comparison of dietary compounds as

precursors of microbial metabolites

• Effect of food structure on metabolite

formation

Pre-clinical screening of processed •

food

• Comparison of the microbial

metabolite profiles with those from

body fluids of man: in vitro-in vivo

correlation

Benefits of VTT’s in vitro colon model

Simple and flexible •

Each experiment include a hypothesis •

with a tailor-made approach

Time course of metabolite formation: •

conversion rate and extent

Initially the same microbiota for all the •

substrates within the experiment

Small standard deviations within •

experiment

Repeatability of the responses between •

different experiments

Potential applicationsDietary fibre/whole grain processing•Release of dietary components from •food matrix (sterols, phenolics, glucose)Conversion of released components •by colonic microbiota

Benefits of the gut microbiota analysis

Diet dependent changes on the gut •

microbiota may directly be studied

Individual responses may be studied•

Correlation between gut microbiota and •

health response may be achieved

Metabolomics platform

Dr. Matej Oresic

Tel. + 358 40 705 5156

[email protected]

Gut microbiota analysis

MSc(Tech) Johanna Maukonen

Tel. + 358 40 518 4971

[email protected]

Technology and market foresight • Strategic research • Product and service development • IPR and licensing • Assessments, testing, inspection, certification • Technology and innovation management • Technology partnership

VTT TECHNICAL RESEARCH CENTRE OF FINLANDwww.vtt.fi